Items where authors include "Dunn, JA"

Article

Escala-Garcia, M, Abraham, J, Andrulis, IL et al. (142 more authors) (2020) A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications, 11 (1). 312.

Drayson, MT, Bowcock, S, Planche, T et al. (23 more authors) (2019) Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. The Lancet Oncology, 20 (12). pp. 1760-1772. ISSN 1470-2045

Drayson, MT, Bowcock, S, Planche, T et al. (13 more authors) (2019) Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT. Health Technology Assessment, 23 (62). pp. 1-94. ISSN 1366-5278

Hall, PS, Smith, A orcid.org/0000-0001-7709-1869, Hulme, C orcid.org/0000-0003-2077-0419 et al. (15 more authors) (2017) Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. Value in Health, 20 (10). pp. 1311-1318. ISSN 1098-3015

Smith, AF orcid.org/0000-0001-7709-1869, Hall, PS, Hulme, C orcid.org/0000-0003-2077-0419 et al. (5 more authors) (2017) Cost-effectiveness analysis of PET-CT guided management for locally advanced head and neck cancer. European Journal of Cancer, 85. pp. 6-14. ISSN 0959-8049

Dorling, L, Kar, S, Michailidou, K et al. (12 more authors) (2016) The relationship between common genetic markers of breast cancer risk and chemotherapy-induced toxicity: A case-control study. PLoS ONE, 11 (7). ISSN 1932-6203

Meads, DM, Marshall, A, Hulme, CT et al. (2 more authors) (2016) The cost-effectiveness of Docetaxel and active symptom control versus active symptom control alone for refractory oesophagogastric adenocarcinoma: Economic analysis of the COUGAR-02 trial. PharmacoEconomics, 34 (1). pp. 33-42. ISSN 1170-7690

Hall, P, Smith, AFC, Vargas-Palacios, A et al. (20 more authors) (2015) UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer. Cancer Research, 75 (9). Abstract P6-08-11. ISSN 0008-5472

Monograph

Mehanna, H, McConkey, CC, Rahman, JK et al. (12 more authors) (2017) PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer. Report. NIHR Journals Library , Health Technology Assessment, Volume 21, Issue 17. ISSN 1366-5278